Follow
← Back
Medicines · Interactions

Clofazimine — interactions

Other medicines, foods and herbal products can change how Clofazimine works. Everything on this page comes from Clofazimine's own FDA-approved label — the same source as the main guide.

← Back to the full Clofazimine guide

⚠ Caution: Substrates of CYP3A4/5: Monitor for toxicities when used concomitantly with LAMPRENE.

Medicines named in Clofazimine's label

Grouped the way the label groups them. Each name links to that medicine's NepalDoc guide; where the label names a class instead of a medicine, the label's words are quoted.

Effect of LAMPRENE on Substrates of CYP3A

Concomitant use of LAMPRENE may increase concentrations of drugs that are substrates of CYP3A4/5 which may increase the risk of toxicity of these drugs. Monitor for toxicities of these drugs when used concomitantly with LAMPRENE.

Section 7.2 of the label

Drugs that Prolong QT Interval QT prolongation and Torsade de Pointes have been reported in patients receiving LAMPRENE in combination with QT prolonging medications, such as bedaquiline. Monitor ECGs for QT prolongation when LAMPRENE is administered with other drugs known to prolong the QT interval .

Clofazimine's label names 1 medicines that NepalDoc also covers.

Their interaction pages

These medicines named in Clofazimine's label have interaction pages of their own:

Read the full interactions section from Clofazimine's label

Substrates of CYP3A4/5: Monitor for toxicities when used concomitantly with LAMPRENE.

7.1 Effect of LAMPRENE on Substrates of CYP3A Concomitant use of LAMPRENE may increase concentrations of drugs that are substrates of CYP3A4/5 which may increase the risk of toxicity of these drugs. Monitor for toxicities of these drugs when used concomitantly with LAMPRENE.

7.2 Drugs that Prolong QT Interval QT prolongation and Torsade de Pointes have been reported in patients receiving LAMPRENE in combination with QT prolonging medications, such as bedaquiline. Monitor ECGs for QT prolongation when LAMPRENE is administered with other drugs known to prolong the QT interval .

Clofazimine guide · All interaction pages · Medicines A–Z

SourcesU.S. FDA-approved label via DailyMed (label effective 17 Aug 2026) · National List of Essential Medicines, Nepal (2021) · U.S. labeling may differ from Nepal DDA-approved labeling and local prescribing practice.

This page summarises Clofazimine's FDA-approved label for information — it is not medical advice. Always tell your doctor or pharmacist about every medicine, supplement and herbal product you take.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.

Share this Medicine
NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.